Beijing Bohui Innovation Biotechnology Group Co., Ltd.

SZSE:300318 Stock Report

Market Cap: CN¥4.7b

Beijing Bohui Innovation Biotechnology Group Past Earnings Performance

Past criteria checks 0/6

Beijing Bohui Innovation Biotechnology Group's earnings have been declining at an average annual rate of -15.8%, while the Medical Equipment industry saw earnings growing at 6.1% annually. Revenues have been growing at an average rate of 10.2% per year.

Key information

-15.8%

Earnings growth rate

-15.8%

EPS growth rate

Medical Equipment Industry Growth16.0%
Revenue growth rate10.2%
Return on equity1.9%
Net Margin-1.7%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

We Think Beijing Bohui Innovation Biotechnology Group (SZSE:300318) Is Taking Some Risk With Its Debt

Sep 30
We Think Beijing Bohui Innovation Biotechnology Group (SZSE:300318) Is Taking Some Risk With Its Debt

Revenue & Expenses Breakdown

How Beijing Bohui Innovation Biotechnology Group makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SZSE:300318 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24885-1528559
30 Jun 241,005-329370
31 Mar 241,055-1031370
31 Dec 231,045-2530769
30 Sep 231,005-2531372
30 Jun 23940-5330066
31 Mar 23873-6027565
01 Jan 23796-7827265
30 Sep 22780-33327778
30 Jun 22749-32627377
31 Mar 22731-32530079
01 Jan 22715-32231081
30 Sep 21772-2632065
30 Jun 21817733160
31 Mar 217581028753
31 Dec 20739826748
30 Sep 20665323340
30 Jun 20605-1520641
31 Mar 20633-520844
31 Dec 19628321247
30 Sep 196485121858
30 Jun 196415421658
31 Mar 196285620956
31 Dec 186226920353
30 Sep 185734118953
30 Jun 185274015371
31 Mar 184894515959
31 Dec 174443916049
30 Sep 174302415231
30 Jun 17401271730
31 Mar 17423231610
31 Dec 16404241560
30 Sep 16415171620
30 Jun 16406151570
31 Mar 16310101380
31 Dec 15269121170
30 Sep 1516122870
30 Jun 1511529700
31 Mar 1510636620
31 Dec 1410138570
30 Sep 149642480
30 Jun 149749400
31 Mar 1410353380
31 Dec 1310754370

Quality Earnings: 300318 is currently unprofitable.

Growing Profit Margin: 300318 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 300318 is unprofitable, and losses have increased over the past 5 years at a rate of 15.8% per year.

Accelerating Growth: Unable to compare 300318's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 300318 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-8.8%).


Return on Equity

High ROE: 300318 has a negative Return on Equity (1.94%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies